The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Olmesartan/Amlodipine Clonmel 40 mg/5 mg film-coated tablets

40 mg/5 milligram(s) Film-coated tablet

Clonmel Healthcare LtdPA0126/293/002

Main Information

Trade NameOlmesartan/Amlodipine Clonmel 40 mg/5 mg film-coated tablets
Active SubstancesOlmesartan Medoxomil
Amlodipine Besilate
Strength40 mg/5 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/293/002

Group Information

ATC CodeC09DB Angiotensin II antagonists and calcium channel blockers
C09DB02 olmesartan medoxomil and amlodipine

Status

Authorised/WithdrawnAuthorised
Licence Issued15/12/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back